Mikihiro Fujiya Selected Research

RNA-Directed DNA Polymerase (Reverse Transcriptase)

8/2015	Polyphosphate, an active molecule derived from probiotic Lactobacillus brevis, improves the fibrosis in murine colitis.
6/2013	MicroRNA-146b improves intestinal injury in mouse colitis by activating nuclear factor-κB and improving epithelial barrier function.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mikihiro Fujiya Research Topics

Disease

45	Neoplasms (Cancer) 03/2024 - 08/2002
15	Inflammation (Inflammations) 01/2022 - 04/2006
12	Ulcerative Colitis 04/2024 - 04/2006
12	Crohn Disease (Crohn's Disease) 01/2024 - 04/2006
10	Stomach Neoplasms (Stomach Cancer) 03/2024 - 08/2002
10	Colitis 01/2021 - 01/2010
9	Adenocarcinoma 03/2024 - 01/2004
9	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 08/2002
8	Pancreatic Neoplasms (Pancreatic Cancer) 02/2024 - 06/2008
7	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 04/2012
7	Colonic Neoplasms (Colon Cancer) 01/2024 - 01/2003
6	Infections 07/2023 - 03/2009
6	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023 - 01/2010
6	Iron Overload 03/2017 - 11/2011
5	Hemorrhage 05/2024 - 10/2011
5	Carcinoma (Carcinomatosis) 03/2024 - 04/2006
5	Non-alcoholic Fatty Liver Disease 10/2023 - 08/2014
4	Fibrosis (Cirrhosis) 01/2018 - 08/2015
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2024 - 01/2016
3	Cholangitis 02/2024 - 06/2019
3	Pathologic Constriction (Stenosis) 03/2022 - 08/2002
3	Hypersensitivity (Allergy) 01/2022 - 08/2017
3	Liver Diseases (Liver Disease) 01/2022 - 01/2015
3	Hypoxia (Hypoxemia) 01/2022 - 08/2010
3	Carcinogenesis 01/2021 - 03/2009
3	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2019
2	Necrosis 04/2024 - 10/2023
2	Esophageal Neoplasms (Esophageal Cancer) 03/2024 - 06/2021
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 03/2024 - 06/2021
2	Weight Loss (Weight Reduction) 03/2024 - 02/2010
2	Sarcoidosis (Schaumann Disease) 01/2024 - 10/2021
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 05/2023 - 01/2020
2	Lymphoma (Lymphomas) 09/2022 - 07/2011
2	Gastritis 07/2022 - 10/2021
2	Diarrhea 01/2022 - 02/2010
2	Melanoma (Melanoma, Malignant) 01/2022 - 10/2021
2	Diverticular Diseases 01/2022 - 08/2015
2	Chemical and Drug Induced Liver Injury 01/2022 - 06/2019
2	Wounds and Injuries (Trauma) 11/2021 - 07/2015
2	Ascites 08/2021 - 08/2017
2	Neoplasms, Cystic, Mucinous, and Serous 12/2020 - 01/2018

Drug/Important Bio-Agent (IBA)

12	Messenger RNA (mRNA)IBA 10/2022 - 06/2008
11	IronIBA 07/2017 - 03/2011
9	Proteins (Proteins, Gene)FDA Link 11/2021 - 01/2011
6	Biomarkers (Surrogate Marker)IBA 08/2021 - 03/2009
6	CytokinesIBA 08/2014 - 04/2006
5	FerrichromeIBA 03/2024 - 10/2016
5	SteroidsIBA 10/2023 - 01/2019
5	Infliximab (Remicade)FDA Link 01/2023 - 01/2013
5	Small Interfering RNA (siRNA)IBA 10/2022 - 06/2013
5	PolyphosphatesIBA 11/2021 - 08/2015
5	Dextrans (Dextran)FDA Link 11/2018 - 11/2011
5	sodium sulfate (sodium bisulfate)FDA LinkGeneric 11/2018 - 11/2011
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2023 - 04/2006
4	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 10/2022 - 11/2015
4	Immune Checkpoint InhibitorsIBA 07/2022 - 06/2020
4	MucinsIBA 01/2022 - 01/2003
4	RNA (Ribonucleic Acid)IBA 01/2021 - 11/2015
4	Dextran SulfateIBA 01/2021 - 01/2010
3	NivolumabIBA 01/2022 - 01/2019
3	Capsules (Microcapsules)IBA 01/2022 - 08/2010
3	MicroRNAs (MicroRNA)IBA 11/2021 - 06/2013
3	AntibodiesIBA 07/2021 - 07/2015
3	DNA (Deoxyribonucleic Acid)IBA 12/2020 - 04/2010
3	RibonucleoproteinsIBA 06/2020 - 11/2015
3	Antimicrobial PeptidesIBA 11/2018 - 01/2010
3	Indicators and Reagents (Reagents)IBA 11/2017 - 12/2015
3	HepcidinsIBA 03/2017 - 02/2014
3	Cadherins (E-Cadherin)IBA 09/2013 - 01/2004
2	carbazochrome (Adona)IBA 05/2024 - 10/2022
2	Ustekinumab (CNTO 1275)FDA Link 04/2024 - 10/2020
2	vedolizumabIBA 04/2024 - 07/2023
2	Fluorouracil (Carac)FDA LinkGeneric 03/2024 - 01/2021
2	Long Noncoding RNAIBA 02/2024 - 01/2021
2	Bevacizumab (Avastin)FDA Link 09/2023 - 12/2022
2	atezolizumabIBA 09/2023 - 12/2022
2	Tumor Biomarkers (Tumor Markers)IBA 09/2023 - 11/2021
2	Hemoglobins (Hemoglobin)IBA 05/2023 - 07/2017
2	Immunologic Factors (Immunomodulators)IBA 11/2022 - 01/2013
2	heptelidic acidIBA 01/2022 - 01/2021
2	Biosimilar PharmaceuticalsIBA 01/2022 - 10/2021
2	CateninsIBA 01/2022 - 01/2017
2	CT-P13IBA 01/2022 - 10/2021
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 08/2021 - 01/2020
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 06/2021 - 01/2020
2	Diatrizoate Meglumine (Gastrograffin)FDA LinkGeneric 01/2021 - 03/2011
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2020
2	Octreotide (Sandostatin)FDA LinkGeneric 01/2021 - 01/2011
2	Codon (Codons)IBA 06/2020 - 08/2002

Therapy/Procedure

28	Therapeutics 03/2024 - 01/2003
11	Drug Therapy (Chemotherapy) 05/2023 - 08/2002
4	Gastrectomy 01/2021 - 09/2008
3	Blood Component Removal (Apheresis) 01/2024 - 08/2021
3	Remission Induction 01/2024 - 08/2021
3	Radiotherapy 05/2023 - 01/2020
3	Chemoradiotherapy 01/2021 - 08/2016
2	Gastrostomy 03/2022 - 03/2011
2	Ligation 01/2022 - 01/2022
2	Molecular Targeted Therapy 11/2021 - 11/2015
2	Lymph Node Excision (Lymph Node Dissection) 01/2021 - 08/2016